PHAP1 Antikörper
Kurzübersicht für PHAP1 Antikörper (ABIN1731807)
Target
Alle PHAP1 (ANP32A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Reacts with synthetic peptide corresponding to amino acids at carboxy terminus of human PHAP I
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic peptide from human ANP32A.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: IHC - P (10 μg/mL), WB (0.5 - 2 μg/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.02 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.
-
-
- PHAP1 (ANP32A) (Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member A (ANP32A))
-
Andere Bezeichnung
- ANP32A
-
Hintergrund
- Implicated in a number of cellular processes, including proliferation, differentiation, caspase-dependent and caspase-independent apoptosis, suppression of transformation (tumor suppressor), inhibition of protein phosphatase 2A, regulation of mRNA trafficking and stability in association with ELAVL1, and inhibition of acetyltransferases as part of the INHAT (inhibitor of histone acetyltransferases) complex. Plays a role in E4F1-mediated transcriptional repression.
-
UniProt
- P39687
Target
-